Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

RSS icon

Survey spurred by ‘general need for more public transparency’ sheds light on editorial leadership at imaging journals

At scientific journals focused on medical imaging, 82% of editors-in-chief and 30% of editorial board members receive financial compensation for these side jobs.

2 imaging technologies cleared for respective markets

The FDA has approved a CT guidance system for interventional radiologists performing percutaneous procedures with robotics. And the European Union has greenlit a family of mobile CT scanners.

mergers acquisitions puzzle M&A

7-state imaging powerhouse consolidates presence in the Garden State

An investor-backed practice in the Northeast has acquired the radiology operations of a practice that runs six imaging centers in New Jersey.

Burnout-busting partnership said to signal ‘a major shift in how physicians will be supported in the future’

A telehealth practice active in all 50 states has hired a similarly sprawling behavioral-health consultancy to provide physicians with pro-wellbeing, anti-burnout counseling and related services.

GE nudges GE HealthCare to the edge of decisive departure

GE HealthCare just got pushed closer to the point at which it will have to spread its wings and fly unassisted from its parent’s nest.

10 industry names in the news of late

No. 4: Amgen supplies HHS with drug used to fight blood cell injuries from acute radiation syndrome in radiological and nuclear emergencies (Oct. 4).

Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

‘Relatively new’ contrast vendor releases second generic agent

A global tech and pharma supplier that introduced a generic equivalent to GE Healthcare’s Visipaque during the height of the 2022 contrast shortage has begun offering a substitute for Guerbet’s Dotarem.

Female Medical Research Scientist Working with Brain Scans

FDA approves AI analysis of high-grade gliomas

An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.

Displaying 689 - 696 of 3058
Design by Adaptive Theme